Endoscopic or combined management of post-surgical biliary leaks: a two-center recent experience.

Background and Aims: Post-surgical biliary leaks (PSBL) are one of the most prevalent and significant adverse events emerging after liver or biliary tract surgeries. Endoscopic retrograde cholangiopancreatography (ERCP) alone or combined with another approach (Rendez Vous) as treatment of PSBL obtains optimal outcomes due to the possibility of modifying the resistances in the biliary tree.
Methods: A retrospective double-center study was conducted in two tertiary centers. Consecutive patients who underwent at least one attempt of PSBL correction by ERCP or Rendez Vous procedure between January 2018 and August 2023 were included. The primary outcome was overall endoscopic clinical success. In contrast, the secondary outcomes were hospital stay exceeding five days and endoscopic clinical success with the first endoscopic procedure at the tertiary center. Both univariate and multivariate analyses were used to assess outcomes.
Results: 65 patients were included. Patients with one or multiple) leaks had more possibility to achieve the endoscopic clinical success compared to those affected by the association of leaks and stricture (96% vs 67%, p value 0.005). Leaks occurring in the main biliary duct had less probability (67%) to achieve the overall endoscopic clinical success compared to those in the end-to-end anastomosis (90%), in the resection plane or biliary stump (96%) or first or secondary order biliary branches (100%, p value 0.038). A leak-bridging stent positioning had more probability of achieving the endoscopic clinical success than a not leak-bridging stent (91% vs 53%, p value 0.005).
Conclusions: ERCP and Rendez Vous procedures are safe and effective for treating PSBL, regardless of the type of preceding surgery, even if technical or clinical success was not achieved on the first attempt. A stent should be placed, if feasible, leak-bridging to enhance treatment efficacy.
Competing Interests: Declarations. Disclosures: Drs. Dario Quintini, Dr. Giacomo Emanuele Maria Rizzo, Dr. Ilaria Tarantino, Dr. Giacomo Sarzo, Dr. Alberto Fantin, Dr. Roberto Miraglia, Dr. Luigi Maruzzelli, Dr. Dario Ligresti, Dr. Lucio Carrozza, Dr. Gabriele Rancatore, Dr. Salvatore Gruttadauria, Dr. Umberto Cillo, Dr. Francesco Ferrara, and Dr Mario Traina have no conflicts of interest or financial ties to disclose.
(© 2024. The Author(s).)